The iRhythm monitoring service provides you with everything your practice needs. From our advanced, yet simple-to-use Zio® ECG monitors15,16 to our elegant data management solutions, we are transforming the world of cardiac monitoring with every heartbeat.
The Total Package
The right mix of clinical accuracy,1 outstanding patient compliance,2 and elegant implementation to streamline your practice like never before.3


An end-to-end cardiac monitoring service

Advanced AI with a human touch
Our FDA-cleared, deep-learned AI algorithm is proven to be as accurate as expert cardiologists,17-20 enabling you to confidently diagnose arrhythmias including atrial fibrillation.1 The iRhythm monitoring service delivers accurate and succinct reports.1 The recorded data is processed by our algorithm, then curated and verified by Qualified Cardiac Technicians.17-20
Keep reading
Continue the conversation


Full support
Questions about products, billing, or our services? We have you covered.
iRhythm offers dedicated support to help with issues like inventory management and customer satisfaction. We even have a specialized billing team to help manage revenue cycle questions and billing inquiries available 24/7/365.
WEB0185.01
- Data on file. iRhythm Technologies, 2023.
- Data on file. iRhythm Technologies, 2022.
- ZioSuite Clinical Reference Manual. iRhythm Technologies, 2022.
- Zio AT Clinical Reference Manual. iRhythm Technologies, 2022.
- Zio AT does not require battery changes or charging. Zio AT has wear time transmission limits and is contraindicated for critical care patients. Refer to the Zio AT Clinical Reference Manual for additional information.
- Zio XT Clinical Reference Manual. iRhythm Technologies, 2019.
- Zio monitor Instructions for Use. iRhythm Technologies, 2023.
- 99% of physicians agree with the comprehensive end-of-wear report. Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports. Data on file. iRhythm Technologies, 2023.
- Reynolds et al. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024;269:25–34. https://doi.org/10.1016/j.ahj.2023.12.002
- A specified arrhythmia refers to an arrhythmia encounter diagnosis as per Hierarchical Condition Categories (HCC) 96.
- Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
- Zio LTCM service refers to Zio XT and Zio monitor service.
- In testing for specified arrhythmias defined by Hierarchical Condition Categories (HCC) 96.
- Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports. Data on file. iRhythm Technologies, 2023.
- Battisti et al. Abstract 4141717: Feasibility of point-of-wear patient satisfaction surveys to validate patient-centered product enhancements: results from over 300,000 patients for long-term ambulatory cardiac monitoring. Circulation. 2024;150:A4141717. doi:10.1161/circ.150.suppl_1.4141717. https://www.ahajournals.org/doi/abs/10.1161/circ.150.suppl_1.4141717
- Data on file. iRhythm Technologies, 2024
- Data on file. iRhythm Technologies 2020.
- Hannun et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-69.https://doi.org/10.1038/s41591-018-0268-3
- Deep-learned algorithm is only available in the United States, European Union, Switzerland, and United Kingdom.
- FDA 510K clearance, CE mark, and UKCA mark.
WEB0002.02